Coriolis Pharma Overview
- Year Founded
-
2008
- Status
-
Private
- Employees
-
192
- Latest Deal Type
-
Later Stage VC
- Investors
-
4
Coriolis Pharma General Information
Description
Operator of a biopharmaceutical research company intended for the development process of biopharmaceutical drugs. The company specializes in formulation research and development of biopharmaceutical drugs and vaccines, and offers analytical services, including method development, qualification and validation, enabling clients to commercialize pharmaceutical products.
Contact Information
Website
www.coriolis-pharma.comCorporate Office
- Fraunhoferstraße 18 b
- 82152 Martinsried
- Germany
Corporate Office
- Fraunhoferstraße 18 b
- 82152 Martinsried
- Germany
Coriolis Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Later Stage VC | 10-Oct-2023 | Completed | Generating Revenue |
Coriolis Pharma Comparisons
Industry
Financing
Details
Coriolis Pharma Competitors (32)
One of Coriolis Pharma’s 32 competitors is Vetter Pharma, a Private Debt Financed company based in Ravensburg, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Vetter Pharma | Private Debt Financed | Ravensburg, Germany | ||||
| KBI BioPharma | Formerly VC-backed | Durham, NC | ||||
| August Bioservices | Venture Capital-Backed | Nashville, TN | ||||
| CordenPharma | Private Equity-Backed | Basel, Switzerland | ||||
| JOINN Biologics | Venture Capital-Backed | Beijing, China |
Coriolis Pharma Patents
Coriolis Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026022093-A1 | Method of evaluating geometric properties in measurement cells in an analytical ultracentrifugation apparatus | Pending | 22-Jul-2024 | ||
| WO-2025202487-A2 | Dupilumab pharmaceutical composition | Pending | 28-Mar-2024 | ||
| WO-2025202487-A3 | Pharmaceutical composition comprising dupilumab | Pending | 28-Mar-2024 | ||
| WO-2024156841-A1 | Biopharmaceutical composition | Inactive | 27-Jan-2023 | ||
| JP-2024517592-A | Fim-cnn for detection of live cells and/or particulate impurities | Pending | 09-Apr-2021 | G06V20/698 |
Coriolis Pharma Signals
Coriolis Pharma Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Flerie | Venture Capital | Minority | ||
| Frontier Biosolutions | PE-Backed Company | Minority | ||
| Global Atlantic Financial Group | PE-Backed Company | Minority | ||
| Kohlberg Kravis Roberts | PE/Buyout | Minority |
Coriolis Pharma Investments (1)
Coriolis Pharma’s most recent deal was a Corporate with U-Medico. The deal was made on 17-Mar-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| U-Medico | 17-Mar-2022 | Corporate | Other Pharmaceuticals and Biotechnology |
Coriolis Pharma FAQs
-
When was Coriolis Pharma founded?
Coriolis Pharma was founded in 2008.
-
Where is Coriolis Pharma headquartered?
Coriolis Pharma is headquartered in Martinsried, Germany.
-
What is the size of Coriolis Pharma?
Coriolis Pharma has 192 total employees.
-
What industry is Coriolis Pharma in?
Coriolis Pharma’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Coriolis Pharma a private or public company?
Coriolis Pharma is a Private company.
-
What is Coriolis Pharma’s current revenue?
The current revenue for Coriolis Pharma is .
-
Who are Coriolis Pharma’s investors?
Flerie, Frontier Biosolutions, Global Atlantic Financial Group, and Kohlberg Kravis Roberts have invested in Coriolis Pharma.
-
Who are Coriolis Pharma’s competitors?
Vetter Pharma, KBI BioPharma, August Bioservices, CordenPharma, and JOINN Biologics are some of the 32 competitors of Coriolis Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process